Fulminant Type I diabetes is a novel subtype of Type I diabetes. In this disease, extremely rapid and almost complete β-cell destruction occurs, resulting in nearly no residual insulin secretion even just after the onset. The number of patients presumably amounts to 5,000~7,000 in Japan. The involvement of both, genetic background and viral infection, has been suggested in the pathogenesis of this disease. Diagnostic criteria were established by a committee of the Japan Diabetes Society in 2004. Intensive insulin therapy is a standard therapy. We should pay special attention to early development of microvascular complications in fulminant Type I diabetes.
CITATION STYLE
Shibasaki, S., Imagawa, A., & Hanafusa, T. (2013). Fulminant type 1 diabetes mellitus: A new class of type 1 diabetes. Advances in Experimental Medicine and Biology, 771, 20–23. https://doi.org/10.1007/978-1-4614-5441-0_3
Mendeley helps you to discover research relevant for your work.